| Vial description: |
Translocator proteineripheral-type benzodiazepine receptorKBSBR, MBR |
| Category: |
control peptide |
| Raised in: |
laboratory |
| Clone: |
1 vial |
| Form: |
pure |
| Reactivity: |
not determined |
| Purity: |
purified |
| Molecular weight: |
in kDa |
| Source: |
mammalian |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
P30536 |
| Application: |
not determined |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
TSPO / BZRP Peptide |
| Short name: |
anti-TSPO / BZRP Control Peptide Antibody |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, controls, Antibody |
| Alternative name: |
antibody to-translocator protein (18kDa) / BZRP reference short protein sequence (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BPBS and BZRP and DBI and IBP and MBR and mDRC and PBR and PBS and pk18 and PKBS and PTBR, TSPO and IDBG-10470 and ENSG00000100300 and 706, TSPO and IDBG-642147 and ENSBTAG00000018073 and 281033, Tspo and IDBG-168372 and ENSMUSG00000041736 and 12257, cholesterol binding, nuclei, this GO :0005497 and androgen binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005739 and mitochondrion and cellular component this GO :0005741 and mitochondrial outer membrane and cellular component this GO :0006626 and protein targeting to mitochondrion and biological process this GO :0006694 and steroid biosynthetic process and biological process this GO :0006783 and heme biosynthetic process and biological process this GO :0006811 and ion transport and biological process this GO :0006820 and anion transport and biological process this GO :0006821 and chloride transport and biological process this GO :0006915 and apoptotic process and biological process this GO :0007268 and synaptic transmission and biological process this GO :0007568 and aging and biological process this GO :0008202 and steroid metabolic process and biological process this GO :0008283 and cell proliferation and biological process this GO :0008347 and glial cell migration and biological process this GO :0008503 and benzodiazepine receptor activity and molecular function this GO :0010042 and response to manganese ion and biological process this GO :0010266 and response to vitamin B1 and biological process this GO :0010940 and positive regulation of necrotic cell death and biological process this GO :0014012 and peripheral nervous system axon regeneration and biological process this GO :0015485 and cholesterol binding and molecular function this GO :0016021 and integral component of membrane and cellular component this GO :0030325 and adrenal gland development and biological process this GO :0031965 and nuclear membrane and cellular component this GO :0032374 and regulation of cholesterol transport and biological process this GO :0032570 and response to progesterone and biological process this GO :0032720 and negative regulation of tumor necrosis factor production and biological process this GO :0033574 and response to testosterone and biological process this GO :0042493 and response to drug and biological process this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0043231 and intracellular membrane-bounded organelle and cellular component this GO :0045019 and negative regulation of nitric oxide biosynthetic process and biological process this GO :0048265 and response to pain and biological process this GO :0048266 and behavioral response to pain and biological process this GO :0048678 and response to axon injury and biological process this GO :0050810 and regulation of steroid biosynthetic process and biological process this GO :0051901 and positive regulation of mitochondrial depolarization and biological process this GO :0051928 and positive regulation of calcium ion transport and biological process this GO :0060242 and contact inhibition and biological process this GO :0060252 and positive regulation of glial cell proliferation and biological process this GO :0060253 and negative regulation of glial cell proliferation and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0071222 and cellular response to lipopolysaccharide and biological process this GO :0071294 and cellular response to zinc ion and biological process this GO :0071476 and cellular hypotonic response and biological process this GO :2000379 and positive regulation of reactive oxygen species metabolic process and biological process, this GO :0005497 : androgen binding, this GO :0005497 : androgen binding and also this GO :0005515 : protein binding and also this GO :0008503 : benzodiazepine receptor activity and also this GO :0015485 : cholesterol binding, this GO :0005515 : protein binding, this GO :0008503 : benzodiazepine receptor activity, this GO :0015485 : cholesterol binding, translocator protein (18kDa) |
| Identity: |
1158 |
| Gene: |
TSPO |
More about : TSPO |
| Long gene name: |
translocator protein |
| Synonyms gene: |
BZRP |
| Synonyms gene name: |
benzodiazapine receptor (peripheral) translocator protein (18kDa) |
| Synonyms: |
PBR MBR PKBS mDRC DBI IBP pk18 |
| Synonyms name: |
peripheral-type benzodiazepine receptor/recognition site |
| Locus: |
22q13, 2 |
| Discovery year: |
1991-05-25 |
| GenBank acession: |
AF075589 |
| Entrez gene record: |
706 |
| Pubmed identfication: |
1326278 1847678 16822554 |
| RefSeq identity: |
NM_007311 |
| Havana BLAST/BLAT: |
OTTHUMG00000150573 |